The Role of MIP-1α in Experimental Hypersensitivity Pneumonitis

被引:0
|
作者
M. Schuyler
K. Gott
V. French
机构
[1] University of New MexicoSchool of Medicine,Department of Medicine, Albuquerque VA Medical Center
来源
Lung | 2004年 / 182卷
关键词
Hypersensitivity pneumonitis; Chemokines;
D O I
暂无
中图分类号
学科分类号
摘要
S. rectivirgula (SR) causes Farmer’s Lung Disease, a classic example of hypersensitivity pneumonitis (HP). We utilized a model of experimental hypersensitivity pneumonitis (EHP), antibody to MIP-1α and MIP-1α−/− mice, to test the hypothesis that MIP-1α is essential in the development of EHP. Treatment of C57BI/6 mice with anti-MIP-1α antibody did not change the extent of pulmonary histology abnormalities, BALF cell number or characteristics, or BALF concentration of IL12p40, TNF, IL1α and IL6, after an i.t. challenge with SR. MIP-1α−/− animals responded similarly to wild-type (wt) animals in the extent and nature of pulmonary histologic changes and BALF cell number and type after a single i.t. injection of SR There was a dose-response relationship between the amount of SR and BALF IL12p40, MCP-1 and IL6 in both strains, and MIP-1α in wild-type animals. We next transferred SR cultured spleen cells from SR sensitized mice (both wt and MIP-1α−/−) to naïve recipients. Lung histology and BALF characteristics after SR i.t. challenge of the recipients were used to determine if adoptive transfer had occurred. Cultured cells from MIP-1α−/− animals were fully capable of transferring EHP to recipients. There was no difference of BALF TNF, IL6 and IL1α between the strains, but there was more MCP-1 and IL12p40 in the MIP-1α−/− mice than in the control mice. MIP-1α is not necessary for the recruitment of cells into the lung and BALF after i.t. administration of SR, or the development of cells able to adoptively transfer EHP.
引用
收藏
页码:135 / 149
页数:14
相关论文
共 50 条
  • [1] The role of MIP-1α in experimental hypersensitivity pneumonitis
    Schuyler, M
    Gott, K
    French, V
    [J]. LUNG, 2004, 182 (03) : 135 - 149
  • [2] The role of MIP-1α and MIP-1β in adoptive transfer models of Type 1 Diabetes
    Meagher, TC
    Arreaza, G
    Cameron, M
    Delovitch, T
    [J]. FASEB JOURNAL, 2001, 15 (04): : A357 - A357
  • [3] The role of MIP-1α in protective immunity
    Dye, JM
    Zajac, AJ
    Quinn, DG
    [J]. FASEB JOURNAL, 2000, 14 (06): : A1097 - A1097
  • [4] Experimental hypersensitivity pneumonitis: Role of MCP-1
    Schuyler, M
    Gott, K
    Cherne, A
    [J]. JOURNAL OF LABORATORY AND CLINICAL MEDICINE, 2003, 142 (03): : 187 - 195
  • [5] MIP-1α and MIP-1β induction by dengue virus
    Spain-Santana, TA
    Marglin, S
    Ennis, FA
    Rothman, AL
    [J]. JOURNAL OF MEDICAL VIROLOGY, 2001, 65 (02) : 324 - 330
  • [6] Role of the autocrine chemokines MIP-1α and MIP-1β in the metastatic behavior of murine T cell lymphoma
    Menten, P
    Saccani, A
    Dillen, C
    Wuyts, A
    Struyf, S
    Proost, P
    Mantovani, A
    Wang, JM
    Van Damme, J
    [J]. JOURNAL OF LEUKOCYTE BIOLOGY, 2002, 72 (04) : 780 - 789
  • [7] The role of MIP-1 alpha in inflammation and hematopoiesis
    Cook, DN
    [J]. JOURNAL OF LEUKOCYTE BIOLOGY, 1996, 59 (01) : 61 - 66
  • [8] Cytokine induction of MIP-1α and MIP-1β in human fetal microglial
    McManus, CM
    Brosnan, CF
    Berman, JW
    [J]. JOURNAL OF IMMUNOLOGY, 1998, 160 (03): : 1449 - 1455
  • [9] Evaluation of the chemokines MIP-1α, MIP-1β and RANTES in human cardiac disease
    Hertz, G
    Tan, CD
    Parrillo, JE
    Rodriguez, ER
    [J]. LABORATORY INVESTIGATION, 1998, 78 (01) : 33A - 33A
  • [10] MIP-1α and MIP-1β differentially mediate mucosal and systemic adaptive immunity
    Lillard, JW
    Singh, UP
    Boyaka, PN
    Singh, S
    Taub, DD
    McGhee, JR
    [J]. BLOOD, 2003, 101 (03) : 807 - 814